爱游戏平台注册登录
check quantity

AlphaLISA SureFire Ultra Human Total CDK1 Detection Kit, 500 Assay Points

The AlphaLISA® SureFire® Ultra Human Total CDK1 assay is a sandwich immunoassay for quantitative detection of total CDK1 in cellular lysates using Alpha Technology.

For research use only; not for diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).

貨號
產品尺寸
ALSU-TCDK1-A500
500 Assay Points
更多
ALSU-TCDK1-A10K
10,000 Assay Points
更多
ALSU-TCDK1-A50K
50,000 Assay Points
更多
ALSU-TCDK1-A-HV
100 Assay Points
更多
Request Technical Support

請輸入有效數量

請登錄以添加收藏夾。

購物車為空

詳細信息

Cyclin-dependent kinase 1 (CDK1), encoded by the CDC2 gene, is a serine/threonine kinase ubiquitously expressed in eukaryotes. CDK1 is a catalytic subunit of a protein kinase called the M-phase promoting factor that induces entry into mitosis. Dysregulated activation of CDK1 leads to uncontrolled cell division and is a hallmark of cancer. Inhibition of CDK1 is an active research area, especially with new approaches involving PROTACs.

The AlphaLISA SureFire Human Total CDK1 Detection Kit is a sandwich immunoassay for the quantitative detection of total CDK1 in cellular lysates, using Alpha Technology.

Formats

  • The HV (high volume) kit contains reagents to run 100 wells in 96-well format, using a 60 μL reaction volume.
  • The 500-point kit contains enough reagents to run 500 wells in 384-well format, using a 20 μL reaction volume.
  • The 10,000-point kit contains enough reagents to run 10,000 wells in 384-well format, using a 20 μL reaction volume.
  • The 50,000-point kit contains enough reagents to run 50,000 wells in 384-well format, using a 20 μL reaction volume.

AlphaLISA SureFire Ultra kits are compatible with

  • Cell and tissue lysates
  • Antibody modulators
  • Biotherapeutic antibodies

Alpha SureFire kits can be used for

  • Cellular kinase assays
  • Receptor activation studies
  • Screening

規格

檢測點(200-50,000) 500 Assay Points
檢測目標 CDK1
檢測技術 Alpha
自動化兼容 Yes
檢測方法 Alpha
實驗類型 In vitro
產品品牌名稱 AlphaLISA SureFire Ultra
運輸條件 藍冰
Target Species Human
治療領域 Oncology
產品尺寸 500 Assay Points
資源
  • 所有

產品手冊

Drug Discovery Screening Solutions Brochure

Find out about our range of integrated solutions for drug discovery screening in this e-brochure.

Our screening solutions for high-throughput screening, phenotypic screening and data analysis help to streamline drug discovery workflows in labs across the globe. Our portfolio includes automat ...

PDF 4 MB
Alpha Technology Solutions

Product brochure for the Alpha Technology, a versatile, no wash, homogeneous assay technology that's suitable for a broad range of applications.

PDF 2 MB

應用文獻

CDK Signaling in Oncology: Evaluate Phosphorylation Events Trigged by DNA Damage

DNA double-strand breaks, like those induced by the widely used chemotherapy drug etoposide, trigger a DNA damage response that activates a variety of repair mechanisms, including the phosphorylation of the histone protein component H2AX. DNA damage can directly affect cell cycle progression by m ...

PDF 1 MB

應用簡報

Eight Limitations of ELISA and How to Overcome Them Using Alternative Technologies

The introduction of enzyme-linked immunosorbent assays (ELISAs) in the early 1970’s offered researchers a non-radiometric immunoassay platform without compromising sensitivity. Over the last 50 years scientists have made huge strides in disease research and drug discovery and a demand for greater ...

PDF 1 MB
Baidu
map